In more detail, catalase-loaded exosomes in a Parkinson’s disease mouse model showed an increase in the quantity of exosomes with catalase-preserved activity detected in the brain and generated more neuroprotective effects than when administrated intravenously [123]. Here, CAT is linked to Parkinson disease.